Immunoprecise Antibodies and InterSystems collaborate to integrate AI-driven healthcare platforms.

Immunoprecise Antibodies (IPA) and InterSystems have collaborated to integrate InterSystems IRIS data platform's vector search capability with BioStrand's LENSai platform, creating AI-driven healthcare applications. This partnership tackles growing data challenges in healthcare and life sciences. The global AI market is expected to reach $1.3 trillion by 2032, showcasing the companies' dedication to innovation.